ARTICLE | Clinical News
Lorediplon: Completed Phase IIa enrollment
September 12, 2016 7:00 AM UTC
Ergomed completed enrollment of >=130 adult insomniacs in a double-blind, placebo-controlled, crossover, international Phase IIa trial comparing 5 and 10 mg oral lorediplon vs. zolpidem. Ferrer is con...